Table 3. Types of inpatient antibiotics prescribed in addition to ceftriaxone, with number of patients and percentage of total population (n=138) and range of duration of inpatient antibiotic coverage (days).

Antibiotic	Number of patients N (%)	Duration range (days)
Vancomycin	63 (46)	1–22
Metronidazole	39 (28)	1–113
Piperacillin-tazobactam	26 (19)	1–23
Levofloxacin	21 (15)	1–43
Ciprofloxacin*	20 (15)	1–14
Cefepime	13 (9)	1–14
Meropenem	8 (6)	1–10
Ampicillin-sulbactam	6 (4)	1–37
Ceftazidime	6 (4)	1–9
Ampicillin	4 (3)	2–7
Azithromycin	4 (3)	1–6
Fluconazole	4 (3)	1–37
Nafcillin	3 (2)	2–6
Clindamycin	3 (2)	2–6
Gentamycin	2 (1)	6–9
Daptomycin	2 (1)	5–7
Amoxicillin	2 (1)	3–6
Trimethoprim- sulphamethoxazole*	1 (<1)	3
Ertapenem	1 (<1)	2
Clarithromycin	1 (<1)	3
Caspafungin	1 (<1)	11
Micafungin	1 (<1)	1
Aztreonam	1 (<1)	2
Moxifloxacin	1 (<1)	2
Linezolid	1 (<1)	9
Cefotaxime	1 (<1)	1
Cefazolin	1 (<1)	3

[[i] *Recorded as treatment. This analysis excluded patients continued on ciprofloxacin or trimethoprim-sulphamethoxazole for prophylaxis.]